PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsFecal microbiota
Fecal microbiota
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
1041 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
InfectionsD007239EFO_0000544212815155108
Clostridium infectionsD003015EFO_1000874A05.211321323485
Ulcerative colitisD003093EFO_0000729K512129823483
ColitisD003092EFO_0003872K52.92328512875
Communicable diseasesD003141614814772
SyndromeD013577610513252
UlcerD014456MPATH_5791522511751
Irritable bowel syndromeD043183EFO_0000555K58211623451
DiarrheaD003967R19.7412421331
Clostridioides difficileD016360NCBITaxon_149661121724
Show 16 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Fecal microbiota transplantationD000069467142063463
Inflammatory bowel diseasesD015212EFO_000376791132847
Crohn diseaseD003424EFO_0000384K50101122544
Intestinal diseasesD007410K63.9111311837
MicrobiotaD0643072412631
RecurrenceD0120082137524
Graft vs host diseaseD006086D89.817321022
Liver cirrhosisD008103EFO_0001422K74.06541021
FibrosisD005355555920
Diabetes mellitusD003920EFO_0000400E08-E13421318
Show 29 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
ObesityD009765EFO_0001073E66.9352834
Healthy volunteers/patients312528
Gastrointestinal microbiomeD00006919622628
DysbiosisD064806651927
Colorectal neoplasmsD01517921517
Autism spectrum disorderD000067877F84.046817
MelanomaD00854537716
NeoplasmsD009369C8011314
Type 1 diabetes mellitusD003922EFO_0001359E1021214
Brain diseasesD001927G93.4065614
Show 103 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Anorexia nervosaD000856EFO_0004215F50.0268
AnorexiaD000855R63.0257
Liver failureD017093K72.9156
Premature birthD047928EFO_0003917O60246
Alzheimer diseaseD000544EFO_0000249F03156
HypersensitivityD006967EFO_0003785T78.40156
HypertensionD006973EFO_0000537I10246
MalnutritionD044342EFO_0008572E40-E46145
ColicD003085R10.83134
AdenocarcinomaD000230134
Show 35 more
Indications Without Phase
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name
INN
Description
Classification
Unknown
Drug class
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID
RxCUI
ChEMBL ID
ChEBI ID
PubChem CID
DrugBank
UNII ID
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
49 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use